333 related articles for article (PubMed ID: 17136648)
1. [Radiofrequency ablation of malignant liver tumors: use of a volumetric necrosis-tumor ratio for local control].
Kühl H; Stattaus J; Kühl B; Boes T; Antoch G; Frilling A; Forsting M
Rofo; 2006 Dec; 178(12):1243-9. PubMed ID: 17136648
[TBL] [Abstract][Full Text] [Related]
2. Histologic evaluation and treatment outcome after sequential radiofrequency ablation and hepatic resection for primary and metastatic tumors.
Hoffman AL; Wu SS; Obaid AK; French SW; Lois J; McMonigle M; Ramos HC; Sher LS; Lopez RR
Am Surg; 2002 Dec; 68(12):1038-43. PubMed ID: 12516804
[TBL] [Abstract][Full Text] [Related]
3. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
[TBL] [Abstract][Full Text] [Related]
4. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
Pompili M; Mirante VG; Rondinara G; Fassati LR; Piscaglia F; Agnes S; Covino M; Ravaioli M; Fagiuoli S; Gasbarrini G; Rapaccini GL
Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: a comparative study.
Chow DH; Sinn LH; Ng KK; Lam CM; Yuen J; Fan ST; Poon RT
J Surg Oncol; 2006 Dec; 94(7):565-71. PubMed ID: 17048238
[TBL] [Abstract][Full Text] [Related]
8. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy.
Choi D; Lim HK; Kim MJ; Lee SH; Kim SH; Lee WJ; Lim JH; Joh JW; Kim YI
Radiology; 2004 Jan; 230(1):135-41. PubMed ID: 14631050
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach".
Livraghi T; Solbiati L; Meloni F; Ierace T; Goldberg SN; Gazelle GS
Cancer; 2003 Jun; 97(12):3027-35. PubMed ID: 12784338
[TBL] [Abstract][Full Text] [Related]
10. Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas.
Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
J Gastroenterol Hepatol; 2009 Feb; 24(2):223-7. PubMed ID: 18823439
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies.
Tepel J; Hinz S; Klomp HJ; Kapischke M; Kremer B
Eur J Surg Oncol; 2004 Jun; 30(5):551-5. PubMed ID: 15135485
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation for unresectable tumors of the liver.
Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
[TBL] [Abstract][Full Text] [Related]
13. Patient factors affecting thermal lesion size with an impedance-based radiofrequency ablation system.
Glaiberman CB; Pilgram TK; Brown DB
J Vasc Interv Radiol; 2005 Oct; 16(10):1341-8. PubMed ID: 16221905
[TBL] [Abstract][Full Text] [Related]
14. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
Zavaglia C; Corso R; Rampoldi A; Vinci M; Belli LS; Vangeli M; Solcia M; Castoldi C; Prisco C; Vanzulli A; Pinzello G
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):196-201. PubMed ID: 18301300
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation with hand-assisted laparoscopic surgery for the treatment of hepatocellular carcinoma in the caudate lobe.
Ishiko T; Beppu T; Sugiyama S; Masuda T; Takahashi M; Komori H; Takamori H; Hirota M; Kanemitu K; Baba H
Surg Laparosc Endosc Percutan Tech; 2008 Jun; 18(3):272-6. PubMed ID: 18574414
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation for the treatment of liver tumors in the caudate lobe.
Seror O; Haddar D; N'Kontchou G; Ajavon Y; Trinchet JC; Beaugrand M; Sellier N
J Vasc Interv Radiol; 2005 Jul; 16(7):981-90. PubMed ID: 16002506
[TBL] [Abstract][Full Text] [Related]
17. [CT-guided radiofrequency ablation of liver metastases from colorectal cancer].
Mahnken AH; Bruners P; Tacke JA; Günther RW
Dtsch Med Wochenschr; 2009 May; 134(19):976-80. PubMed ID: 19401962
[TBL] [Abstract][Full Text] [Related]
18. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S
Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189
[TBL] [Abstract][Full Text] [Related]
19. [Radiofrequency ablation for hepatocellular carcinoma and liver metastases].
Yasumoto T; Murakami T; Katsumoto Y; Hashimoto T; Noda S; Murata K; Kinuta M; Nakamura H
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1596-9. PubMed ID: 16315881
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma.
Lam VW; Ng KK; Chok KS; Cheung TT; Yuen J; Tung H; Tso WK; Fan ST; Poon RT
J Am Coll Surg; 2008 Jul; 207(1):20-9. PubMed ID: 18589357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]